Breaking News

ADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology

SAN DIEGO–(Small business WIRE)–ADARx Prescribed drugs, Inc., a biotechnology organization developing RNA-targeting therapeutics, now introduced the expansion of their management staff and development capabilities as a result of the appointment of Andrew Seacat, Ph.D., Government Director and Head of Toxicology. “I am delighted to welcome Andrew to the ADARx team, as his wealth of experience […]